ZA201903749B - Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome - Google Patents
Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndromeInfo
- Publication number
- ZA201903749B ZA201903749B ZA2019/03749A ZA201903749A ZA201903749B ZA 201903749 B ZA201903749 B ZA 201903749B ZA 2019/03749 A ZA2019/03749 A ZA 2019/03749A ZA 201903749 A ZA201903749 A ZA 201903749A ZA 201903749 B ZA201903749 B ZA 201903749B
- Authority
- ZA
- South Africa
- Prior art keywords
- alleviating
- preventing
- carbamate compound
- tremor syndrome
- treating tremors
- Prior art date
Links
- 206010044565 Tremor Diseases 0.000 title 2
- -1 carbamate compound Chemical class 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160170225 | 2016-12-14 | ||
| PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201903749B true ZA201903749B (en) | 2022-01-26 |
Family
ID=62558966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2019/03749A ZA201903749B (en) | 2016-12-14 | 2019-06-11 | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11033531B2 (https=) |
| EP (1) | EP3556364B1 (https=) |
| JP (1) | JP7086076B2 (https=) |
| KR (1) | KR102635941B1 (https=) |
| CN (1) | CN110267657B (https=) |
| AU (1) | AU2017374459B2 (https=) |
| CL (1) | CL2019001623A1 (https=) |
| ES (1) | ES3039979T3 (https=) |
| IL (1) | IL267191B2 (https=) |
| MX (1) | MX391363B (https=) |
| MY (1) | MY198417A (https=) |
| WO (1) | WO2018111009A1 (https=) |
| ZA (1) | ZA201903749B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3711760B1 (en) * | 2017-11-14 | 2024-02-14 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current |
| US20220117941A1 (en) * | 2018-09-21 | 2022-04-21 | Sk Biopharmaceuticals Co., Ltd. | Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1262272C (zh) | 2001-02-27 | 2006-07-05 | 奥索-麦克尼尔药品公司 | 用于预防或治疗运动障碍的氨基甲酸酯化合物 |
| EP1732564A1 (en) | 2004-03-29 | 2006-12-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| CA2679206C (en) * | 2007-03-05 | 2015-02-24 | Indus Biotech Private Limited | Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| PL2445890T3 (pl) | 2009-06-22 | 2016-02-29 | Sk Biopharmaceuticals Co Ltd | Sposób wytwarzania estru (R)-1-arylo-2-tetrazoliloetylowego kwasu karbaminowego |
| US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| EP2968210B1 (en) | 2013-03-12 | 2024-09-11 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy |
| KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 MX MX2019006941A patent/MX391363B/es unknown
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko not_active Ceased
- 2017-12-14 EP EP17880232.8A patent/EP3556364B1/en active Active
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 ES ES17880232T patent/ES3039979T3/es active Active
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
- 2017-12-14 MY MYPI2019003351A patent/MY198417A/en unknown
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active Active
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018111009A1 (ko) | 2018-06-21 |
| JP2020502137A (ja) | 2020-01-23 |
| MX2019006941A (es) | 2019-09-06 |
| CN110267657A (zh) | 2019-09-20 |
| RU2019121914A3 (https=) | 2021-04-21 |
| IL267191B2 (en) | 2023-05-01 |
| IL267191B1 (en) | 2023-01-01 |
| CL2019001623A1 (es) | 2019-08-23 |
| ES3039979T3 (en) | 2025-10-28 |
| CN110267657B (zh) | 2022-12-13 |
| BR112019012000A2 (pt) | 2019-10-29 |
| MX391363B (es) | 2025-03-21 |
| KR20190087573A (ko) | 2019-07-24 |
| IL267191A (https=) | 2019-07-31 |
| EP3556364A1 (en) | 2019-10-23 |
| RU2019121914A (ru) | 2021-01-15 |
| MY198417A (en) | 2023-08-29 |
| AU2017374459B2 (en) | 2023-04-27 |
| US11033531B2 (en) | 2021-06-15 |
| EP3556364B1 (en) | 2025-08-27 |
| KR102635941B1 (ko) | 2024-02-13 |
| EP3556364A4 (en) | 2020-06-17 |
| AU2017374459A1 (en) | 2019-07-04 |
| CA3046300A1 (en) | 2018-06-21 |
| US20190336481A1 (en) | 2019-11-07 |
| JP7086076B2 (ja) | 2022-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264049A (en) | Compounds, preparations and methods for treating the disease | |
| DK3658539T3 (da) | Forbindelser og sammensætninger til behandling af tilstande, som er forbundet med nlrp-aktivitet | |
| IL264156A (en) | Compounds, preparations and methods for treating the disease | |
| IL256056A (en) | Ezh2 inhibitors for treating lymphoma | |
| ZA201708039B (en) | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses | |
| PL3109223T3 (pl) | Mieszanina do obróbki nawozów zawierających mocznik | |
| WO2014165090A8 (en) | Compounds for the treatment of tuberculosis | |
| DK3624796T3 (da) | Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse | |
| PT3519569T (pt) | Vetores de vírus adenoassociados para o tratamento de mucopolissacaridoses | |
| PL3065732T3 (pl) | Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii | |
| IL262825A (en) | Tetrahydropyridine and tetrahydropyrimidine substances, preparations containing them and their use for pain treatment | |
| PL3384915T3 (pl) | Karymycyna do leczenia zakażeń prątkiem gruźlicy | |
| PL3459543T3 (pl) | Związek karbaminianowy do zapobiegania lub leczenia fibromialgii | |
| ZA201906047B (en) | Compounds for treating tuberculosis | |
| IL251456A0 (en) | Substances with agonist activity for gpr119, processes for their preparation and preparations containing them | |
| EP2982378A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE | |
| ZA201903749B (en) | Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome | |
| ZA201903747B (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| IL274428B1 (en) | Use of a carbamate compound to prevent, alleviate, or treat a dissociative seizure or epilepsy presenting with a dissociative seizure | |
| PT3459542T (pt) | Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal | |
| IL274084A (en) | Comb for the treatment of dandruff | |
| ZA201901948B (en) | Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections | |
| GB201614609D0 (en) | Compounds for treatment of intractable epilepsy and doors syndrome | |
| GB201701928D0 (en) | Compounds for the treatment of hyperglycaemia | |
| GB201603882D0 (en) | Compounds for the treatment of type 2 diabetes |